filmov
tv
Capivasertib in Advanced Breast Cancer | NEJM
Показать описание
Appropriate endocrine therapy is unclear for hormone receptor–positive, HER2-negative advanced breast cancer that progresses despite treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor.
New research findings are summarized in this short video.
New research findings are summarized in this short video.
0:02:15
0:05:28
0:02:27
0:21:42
0:01:49
0:01:29
0:14:02
0:02:09
0:01:22
0:04:07
0:01:25
0:02:19
0:02:57
1:57:39
0:02:08
0:03:21
1:18:51
0:44:21
0:01:18
0:01:45
0:01:21
0:34:33
0:22:39
0:03:35